Please check your internet connection and try again.
# Arsil-DX
## Overview
Arsil-DX (or similar trade names) generally refers to a combination product containing **Dextromethorphan HBr** (antitussive) and **Chlorpheniramine Maleate** (first-generation antihistamine). It is utilized for the symptomatic relief of cough and upper respiratory symptoms associated with the common cold or allergic rhinitis.
## Primary Indications
Symptomatic relief of cough, sneezing, rhinorrhea, and lacrimation due to the common cold or upper respiratory allergies.
## Adult Dosing
* **Standard dose:** 10–20 mg (Dextromethorphan) / 4 mg (Chlorpheniramine) every 4–6 hours as needed.
* **Maximum daily dose:** Do not exceed 120 mg of Dextromethorphan or 24 mg of Chlorpheniramine in a 24-hour period.
## Pediatric Dosing
* **Children 6 to 12 years:** 5–10 mg (Dextromethorphan) / 2 mg (Chlorpheniramine) every 4–6 hours as needed. Maximum 60 mg/12 mg per 24 hours.
* **Children < 6 years:** Generally **not recommended** due to lack of safety/efficacy data and risk of toxicity.
* *Note: Always consult institutional/local pediatric prescribing protocols, as many OTC cough/cold combinations are contraindicated or discouraged for children under 6 by the FDA and AAP.*
## Dose Adjustments
* **Renal/Hepatic Impairment:** If product is a combination, defer to guidelines for the individual components. Generally, decrease frequency or dose in severe impairment; monitor for increased sedation.
* **Geriatric:** Use caution due to increased risk of anticholinergic side effects (urinary retention, confusion, sedation) associated with Chlorpheniramine.
## Contraindications
* Hypersensitivity to any component.
* Concomitant use with Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of MAOI discontinuation (risk of serotonin syndrome).
* Narrow-angle glaucoma, symptomatic prostatic hypertrophy, or bladder neck obstruction (due to antihistamine component).
## Adverse Effects
* **Common:** Drowsiness, dizziness, dry mouth, thickened respiratory secretions, blurred vision.
* **Serious:** Urinary retention, paradoxical excitation (especially in children), serotonin syndrome (if combined with serotonergic agents), constipation.
## Key Drug Interactions
* **MAOIs:** Absolute contraindication due to risk of hypertension and serotonin syndrome.
* **CNS Depressants:** Alcohol, opioids, or benzodiazepines will potentiate sedative effects.
* **Serotonergic Agents:** SSRIs/SNRIs may increase the risk of serotonin syndrome when taken with Dextromethorphan.
## Monitoring
* Monitor for symptom relief and duration of use (discontinue if symptoms persist > 7 days).
* Monitor for signs of CNS depression or anticholinergic toxicity.
* Assess for misuse/abuse potential of Dextromethorphan.
## Clinical Pearls
* **Safety Warning:** Combination products carry a high risk of "double-dosing" if patients are simultaneously taking other OTC cold medications. Check labeling for acetaminophen or other active ingredients.
* **Anticholinergic Profile:** Chlorpheniramine is sedating. Recommend caution with driving or operating machinery.
* **Efficacy:** Evidence for over-the-counter cough/cold products in pediatric patients is limited; non-pharmacological interventions (hydration, humidification) are often preferred for children.
***
**Disclaimer:** This information is for educational purposes only. Clinical guidelines and formulations may vary. Always verify specific dosing, safety data, and local formulary protocols against the current manufacturer's prescribing information (PI) or institutional clinical decision support tools before prescribing or administering medication.
